ESCRS - PO835 - Analysis Of Corneal Epithelial Thickness With Corneal Epithelium Mapping Pre And Post Treatment With Photo-Therapeutic Keratectomy Or Alcohol Delamination For Recurrent Corneal Erosion Syndrome.

Analysis Of Corneal Epithelial Thickness With Corneal Epithelium Mapping Pre And Post Treatment With Photo-Therapeutic Keratectomy Or Alcohol Delamination For Recurrent Corneal Erosion Syndrome.

Published 2024 - 42nd Congress of the ESCRS

Reference: PO835 | Type: Poster | DOI: 10.82333/hwhx-sv31

Authors: Adam Ferguson* 1 , Ahmed Abdelmaksoud 1 , Abhinav Loomba 1 , Sid Goel 1 , Lucy Hook 1

1Ophthalmology,Hull Royal Infirmary,Hull,United Kingdom

Purpose

Corneal epithelium mapping can be performed using corneal topography. Currently there is a lack of literature on how corneal epithelial mapping can be used to help in the management process of recurrent corneal erosion syndrome. We have analysed patients presenting with recurrent corneal erosion syndrome and how corneal epithelium mapping can be used to improve management pre and post surgical intervention with photo-therapeutic keratectomy or alcohol delamination. 

Setting

Thirty patients data who presented to the corneal service at Hull Royal infirmary over a 12 month period was used to analyse corneal epithelial mapping pre and post surgical intervention for recurrent corneal erosion syndrome. Surgical intervention included photo-therapeutic keratectomy or alcohol delamination.

Methods

We reviewed corneal epithelial mapping pre and post surgical intervention for recurrent corneal erosion syndrome to anakyse the effect on the cornea epithelium.

Results

Corneal epithelium mapping can often show where the affected epithelium is located in recurrent corneal erosion syndrome. This often shows up as thickening of the corneal epithelium. This can be used as part of the management planning process and helps guide treatment so that only affected areas of the cornea undergo treatment.

Conclusions

Corneal epithelial mapping is a useful tool in managing patients who have undergone surgical intervention for recurrent corneal erosion syndrome.